Literature DB >> 15181136

Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.

Jin-Haeng Chung1, Kyung-Ja Cho, Seung-Sook Lee, Hee Jong Baek, Jong-Ho Park, Gi Jeong Cheon, Chang-Woon Choi, Sang Moo Lim.   

Abstract

UNLABELLED: The evaluation of mediastinal lymph node involvement in non-small cell lung carcinoma (NSCLC) is very important for the selection of surgical candidates. PET using (18)F-FDG has remarkably improved mediastinal staging in NSCLC. However, false (18)F-FDG PET results remain a problem. This study was undertaken to identify histologic and immunohistochemical differences between cases showing false and true results of mediastinal lymph node involvement assessed by (18)F-FDG PET.
METHODS: Preoperative (18)F-FDG PET examinations were performed on 62 patients with NSCLC, and mediastinal lymph node sampling was done at thoracotomy or mediastinoscopy. In 111 lymph nodes, the size, glucose transporter 1 (Glut1) expression, grade of follicular hyperplasia, and involved proportion of tumor were examined and compared with the (18)F-FDG PET findings.
RESULTS: Lymphoid follicular cells were strongly positive for the expression of Glut1. The grade of follicular hyperplasia in false-positive lymph nodes was higher than that in true-negative nodes (P < 0.001). The Glut1 expression of metastatic tumors was higher in true-positive nodes than that in false-negative nodes (P < 0.001). Metastatic squamous cell carcinomas showed stronger Glut1 expression than adenocarcinomas and no false-negative results on (18)F-FDG PET. On the other hand, metastatic adenocarcinomas exhibited focal and weak Glut1 expression with frequent false-negative results.
CONCLUSION: The results of this study indicate that (a). lymphoid follicular hyperplasia with Glut1 overexpression may have a causal relationship with high (18)F-FDG uptake of false-positive nodes and (b). the lower expression of Glut1 in metastatic tumors, such as adenocarcinomas, might be responsible for false-negative lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181136

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

Review 1.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 2.  False-positive FDG PET uptake--the role of PET/CT.

Authors:  Sandra J Rosenbaum; Thomas Lind; Gerald Antoch; Andreas Bockisch
Journal:  Eur Radiol       Date:  2005-12-17       Impact factor: 5.315

3.  Tenosynovial Giant Cell Tumor of Diffuse Type Mimicking Bony Metastasis Detected on F-18 FDG PET/CT.

Authors:  Kyoung Jin Chang; Byung Hyun Byun; Han Sol Moon; Jihyun Park; Jae Soo Koh; Byung Il Kim; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2014-04-23

4.  18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer.

Authors:  Mi Rye Bae; Jong-Lyel Roh; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-12       Impact factor: 4.553

5.  Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer.

Authors:  Seong Young Kwon; Jung-Joon Min; Ho-Chun Song; Chan Choi; Kook-Joo Na; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2011-05-12

6.  Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.

Authors:  Hendra Budiawan; Gi Jeong Cheon; Hyung-Jun Im; Soo Jin Lee; Jin Chul Paeng; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-21

7.  Reactive tonsillar enlargement showing strong 18F-FDG uptake during the follow-up of follicular lymphoma.

Authors:  Patricia do Socorro Queiroz Feio; Camilla Borges Ferreira Gomes; Alexandre Simões Nogueira; Luciana Yamamoto Almeida; José Vassallo; Fernando Augusto Soares; Oslei Paes Almeida; Jorge Esquiche León
Journal:  Head Neck Pathol       Date:  2012-09-26

8.  Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.

Authors:  Katsuo Usuda; Motoyasu Sagawa; Hirokazu Aikawa; Masakatsu Ueno; Makoto Tanaka; Yuichiro Machida; Xi-Tong Zhao; Yoshimichi Ueda; Koutaro Higashi; Tsutomu Sakuma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-08-12

9.  A systemic review of PET and biology in lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Noriaki Sunaga; Tamotsu Ishizuka; Kimihiro Shimizu; Nobuyuki Yamamoto
Journal:  Am J Transl Res       Date:  2011-07-27       Impact factor: 4.060

Review 10.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.